HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.

Abstract
Experimental autoimmune myasthenia gravis (EAMG), a disorder of the neuromuscular junction, is mediated by autoantibodies against muscle nicotinic acetylcholine receptor (AChR). The roles of IFN-gamma (Th1) and IL-4 (Th2) cytokines in the initiation and progression of this disease are not fully understood. Recently, we have demonstrated that IFN-gamma is necessary for the initiation of tAChR-induced EAMG in mice. However, the role of IL-4 in the progression of clinical EAMG remained undetermined. In this study we have addressed the contribution of IL-4 in the disease progression in IL-4(-/-) C57BL/6j mice whose IL-4 gene has been disrupted. Following immunization with Torpedo (t) AChR, the IL-4(-/-) mice readily developed signs of muscle weakness and succumbed to clinical EAMG with kinetics similar to the susceptibility of IL-4(+/+) mice. The tAChR-primed lymph node cells from IL-4(-/-) mice vigorously proliferated to tAChR and to its dominant alpha146-162 sequence associated with disease pathogenesis. However, these T cells secreted higher levels of IFN-gamma and IL-2, suggesting the development of a Th1 default pathway in these mice. Nevertheless, the IL-4 mutation had no effect on the recruitment of CD4+ Vbeta6+ T cells specific to the dominant tAChR alpha146-162 sequence in vivo. Immune sera from IL-4(-/-) mice showed a dramatic increase in mouse AChR-specific IgG2a levels followed by a concomitant decrease in IgG1 levels, but these mice did not exhibit an accelerated disease. In conclusion, we have demonstrated for the first time that IL-4 is not required either for the generation of a pathogenic anti-AChR humoral immune response or for progression of clinical EAMG in mice.
AuthorsB Balasa, C Deng, J Lee, P Christadoss, N Sarvetnick
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 161 Issue 6 Pg. 2856-62 (Sep 15 1998) ISSN: 0022-1767 [Print] United States
PMID9743346 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Cytokines
  • Immunodominant Epitopes
  • Immunoglobulin G
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, Nicotinic
  • Interleukin-4
Topics
  • Amino Acid Sequence
  • Animals
  • Autoantibodies (biosynthesis, blood, physiology)
  • Cytokines (biosynthesis)
  • Disease Progression
  • Gene Deletion
  • Immunization
  • Immunodominant Epitopes (immunology)
  • Immunoglobulin G (biosynthesis)
  • Interleukin-4 (genetics, physiology)
  • Lymphocyte Activation (genetics)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Molecular Sequence Data
  • Myasthenia Gravis (etiology, genetics, immunology)
  • Receptors, Antigen, T-Cell, alpha-beta (biosynthesis)
  • Receptors, Nicotinic (immunology)
  • T-Lymphocyte Subsets (immunology, metabolism)
  • Th2 Cells (immunology, metabolism)
  • Torpedo (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: